Our Team
Board of Directors
Rick Doblin, Ph.D., Founder and President
Rick Doblin, Ph.D., is the Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs.…
David Bronner, Board of Directors
Independent Voting Member David Bronner is Cosmic Engagement Officer (CEO) of Dr. Bronner’s, the top-selling brand of natural soaps in North America and producer of a range of organic body care and food products. He is a grandson of company founder, Emanuel Bronner, and a fifth-generation soapmaker. David and Michael established Dr. Bronner’s as a…
Vicky Dulai, Board Chair
Independent Voting Member Vicky Dulai is an independent psychedelic philanthropic consultant. She advises philanthropists and foundations about emerging opportunities in psychedelic research, treatment, and therapist training. Vicky is the founder of Compassion For Addiction, a non-profit dedicated to a trauma informed and psychedelic medicine approach to treating addiction. She was the first female board member…
Staff
Rick Doblin, Ph.D., Founder and President
Rick Doblin, Ph.D., is the Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs.…
Betty Aldworth, Interim Co-Executive Director
Betty Aldworth serves as the Director of Communications & Education at MAPS. With the Communications team, Betty works to share MAPS’ story with our audiences and generate support for psychedelic research and reform through the media. Betty also works with colleagues and allies across the drug policy reform movement to Illustrate the promise of a…
Ismail L. Ali, J.D., Interim Co-Executive Director
Ismail Lourido Ali, JD (he/him or they/them) has been personally utilizing psychedelics and other substances in celebratory and spiritual contexts for over half his life, and has been actively participating in the drug policy reform movement for a decade. As the Director of Policy & Advocacy at the Multidisciplinary Association of Psychedelic Studies (MAPS), Ismail…